Nuvectis Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $18.6M
Liabilities Breakdown FY2024
Total Liabilities: $8.9M
Asset Breakdown
Total Assets: $18.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $18.5M | 99.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $74.0K | 0.4% |
Liabilities Breakdown
Total Liabilities: $8.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.5M | 28.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.4M | 71.9% |